News & Updates
Filter by Specialty:
CNS complications in COVID-19: 1 in 100 hospitalized patients affected
A large retrospective study conducted in the US and Europe and presented at RSNA 2021 has suggested that central nervous system (CNS) complications may affect approximately one in 100 patients hospitalized with COVID-19.
CNS complications in COVID-19: 1 in 100 hospitalized patients affected
27 Dec 2021
Sintilimab-IBI305-chemo improves PFS in EGFRm non-squamous NSCLC
The combination of the anti-PD-1 monoclonal antibody sintilimab with the bevacizumab biosimilar IBI305 and pemetrexed and cisplatin chemotherapy improved progression-free survival (PFS) in patients with EGFR*-mutated (EGFRm) non-squamous non-small-cell lung cancer (NSCLC), according to interim analysis results of the phase III ORIENT-31 trial from China.
Sintilimab-IBI305-chemo improves PFS in EGFRm non-squamous NSCLC
24 Dec 2021
Foetal brain unaffected by mild-to-moderate COVID-19 in pregnancy
Mild-to-moderate COVID-19 during pregnancy does not appear to affect the foetal brain, according to a prospective study presented at RSNA 2021.
Foetal brain unaffected by mild-to-moderate COVID-19 in pregnancy
20 Dec 2021
Extracorporeal CO2 removal safe, effective for acute exacerbation of COPD
Extracorporeal CO2 removal (ECCO2R) devices significantly improve pH and carbon dioxide arterial pressure (PaCO2) in patients with acute exacerbation of chronic obstructive pulmonary disease (ae-COPD) who had previously failed noninvasive ventilation (NIV), according to a recent study.
